{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2222, 
        2231
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2234, 
        2250
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1597, 
        1605
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2154, 
        2169
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2179, 
        2183
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1669, 
        1684
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2205, 
        2213
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2171, 
        2177
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2214, 
        2221
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 9^9999^MOH|PIMS|CCO|20160601235546|8E5E3F25058D009336038E9DC2218C0B6D3D0671|ORU^R01|999999999999|P|2.5||||||\nPID|1||N999999999^^^^CMR^HOSPITAL 9&9999&MOH~N999999999^^^^MRN^HOSPITAL 9&9999&MOH~9999999999&MM&ON^^^^JHN||XXXXXXXXX XXXXXXX^XXXXX^^^^^||99999999|F|||99 XXXXXXXXX XXXX^^XXXXXXXX^XX^X9X 9X9^999|||||||||||||||||||N|||\nOBR|1||S16-11258|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||20160502|||56746^XXXXXXX^XXXX^^^^||||||||||||20160601|||C|||||||99999^XXXX^XXXXXXXX^^^^|||||||\n\n\n\n\n\n\n\nADDENDUMS\n\nESTROGEN AND PROGESTERONE RECEPTOR PROTEIN IMMUNOHISTOCHEMISTRY\nDIAGNOSIS:\nINVASIVE CARCINOMA:\n- POSITIVE FOR ESTROGEN RECEPTORS\n- POSITIVE FOR PROGESTERONE RECEPTORS\nRESULT:\n(Block A1)\n>95% of cell nuclei are positive for estrogen receptors, strong\n>85% of cell nuclei are positive for progesterone receptors, moderate\nAntibody used:\nEstrogen receptor (Rabbit monoclonal, Clone SP1, Ventana)\nProgesterone receptor (Rabbit Monoclonal, Clone 1E2, Ventana)\nPositive and negative external laboratory controls, and internal\ncontrol normal breast tissue stained appropriately.\n\nThreshold for interpretation of Estrogen and Progesterone\nreceptors as per CCO guidelines:\nPOSITIVE: 10% or more of tumor cell nuclei stain positively with any intensity\nLOW POSITIVE: 1-9% of tumor cell nuclei stain positively with any intensity\nNEGATIVE: <1% of tumor cell nuclei stain positively with any intensity\nReference:\nDiaz LK, Sneige N: Estrogen receptor analysis for breast cancer: current\nissues and keys to increasing testing accuracy. Adv Anat Pathol\n2005;12:10-19\n\n\nCOMMENTS\n\nSpecimen:\nExcision time: 1415\nTime placed in Formalin: 1420\n\n\nGROSS PATHOLOGY\n\nThe specimen is received in formalin, labeled with the patient's name and as \"left breast 12 o'clock mass\". The specimen consists of three\ngray to tan-brown, fragments of a core needle biopsy specimen measuring 1.5 cm,\n1.1 cm, and 1.7 cm in length and each measuring up to 0.2 cm in diameter. The entire\nspecimen is submitted as follows:\nA1:    two fragments\nA2:    one fragment                      /KS\n\n\nTISSUE SUBMITTED\n\nBREAST BIOPSY (LT BREAST 12 O CLOCK MASS)\n\n\nFINAL DIAGNOSIS\n\nBREAST (LEFT), CORE BIOPSY:\n   -  INVASIVE MAMMARY CARCINOMA\n\n\nCLINICAL HISTORY\n\nLT BREAST MASS\n\n\n"
}